{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:20:18Z","timestamp":1783941618727,"version":"3.55.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The NIH joint\/fascia score and total P-ROM score should be used for assessing therapeutic response in joint\/fascia chronic GVHD. A change from 0 to 1 on the NIH joint\/fascia score should not be considered as worsening.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000918","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:53:36Z","timestamp":1578052416000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"first","affiliation":[{"name":"Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Onstad","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E. D.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Taussig Cancer Institute\/Cleveland Clinic Foundation, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan H.","family":"Jagasia","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Vanderbilt University, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1215","authenticated-orcid":false,"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Pidala","sequence":"additional","affiliation":[{"name":"Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Pusic","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia B.","family":"Vogelsang","sequence":"additional","affiliation":[{"name":"Department of Oncology, John Hopkins University School of Medicine, Lutherville, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[{"name":"Oncology, Hematology and Rheumatology, Medical Clinic III, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"issue":"4","key":"2020010311533115200_B1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2020010311533115200_B2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7326\/0003-4819-120-12-199406150-00004","article-title":"Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases","volume":"120","author":"Janin","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"2020010311533115200_B3","first-page":"258","article-title":"Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome","volume":"91","author":"Skert","year":"2006","journal-title":"Haematologica"},{"issue":"15","key":"2020010311533115200_B4","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2020010311533115200_B5","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2020010311533115200_B6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3324\/haematol.2018.195123","article-title":"A phase II\/III randomized, multicenter trial of prednisone\/sirolimus versus prednisone\/ sirolimus\/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801","volume":"103","author":"Carpenter","year":"2018","journal-title":"Haematologica"},{"issue":"12","key":"2020010311533115200_B7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2020010311533115200_B8","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.38697","article-title":"Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al","volume":"66","author":"Kuzmina","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2020010311533115200_B9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2020010311533115200_B10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"2020010311533115200_B11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020010311533115200_B12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2016-08-686659","article-title":"Mechanistic approaches for the prevention and treatment of chronic GVHD","volume":"129","author":"Cutler","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2020010311533115200_B13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.38293","article-title":"Assessment of joint and fascia manifestations in chronic graft-versus-host disease","volume":"66","author":"Inamoto","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"2020010311533115200_B14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbmt.2011.05.007","article-title":"Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD","volume":"17","author":"Chronic GVHD Consortium","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2020010311533115200_B15","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.bbmt.2018.02.010","article-title":"Design and patient characteristics of the chronic graft-versus-host disease response measures validation study","volume":"24","author":"Chronic GVHD Consortium","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2020010311533115200_B16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020010311533115200_B17","volume-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"issue":"2","key":"2020010311533115200_B18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/sim.3478","article-title":"Fixed effects, random effects and GEE: what are the differences?","volume":"28","author":"Gardiner","year":"2009","journal-title":"Stat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/1\/40\/1550823\/advancesadv2019000918.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/1\/40\/1550823\/advancesadv2019000918.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:53:44Z","timestamp":1578052424000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/1\/40\/430034\/Refined-National-Institutes-of-Health-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000918","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]}}}